How big is the China Nuclear Imaging Market?

The China Nuclear Imaging Market size is expected to reach USD 348.26 million in 2024 and grow at a CAGR of 4.11% to reach USD 425.96 million by 2029. Read More

What is the current China Nuclear Imaging Market size?

In 2024, the China Nuclear Imaging Market size is expected to reach USD 348.26 million. Read More

Who are the key players in China Nuclear Imaging Market?

Bracco Imaging SpA, Canon Inc., Koninklijke Philips NV, Cardinal Health Inc. and General Electric Company (GE HealthCare) are the major companies operating in the China Nuclear Imaging Market. Read More

What years does this China Nuclear Imaging Market cover, and what was the market size in 2023?

In 2023, the China Nuclear Imaging Market size was estimated at USD 334.51 million. The report covers the China Nuclear Imaging Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the China Nuclear Imaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

China Nuclear Imaging Market Share

Statistics for the 2023 & 2024 China Nuclear Imaging market share, created by Mordor Intelligence™ Industry Reports. China Nuclear Imaging share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of China Nuclear Imaging Industry

The market comprises major market players, and these players are focusing on R&D to strengthen their position in the market. The market has been noticing technological developments on a large scale in Nuclear Imaging Systems and Nuclear Medicine Equipment over the past couple of years. Some of the market players are Bayer AG, Bracco Imaging SpA, Canon Inc., Cardinal Health Inc., China Isotope & Radiation Corporation (CIRC), Curium Pharma, General Electric Company (GE HealthCare), Global Medical Solutions Ltd, Koninklijke Philips NV, Siemens Healthcare GmbH, and Yantai Dongcheng Pharmaceutical Group Co. Ltd.